EGFR and glioblastoma: In patient #8, RC-seq detected a putative tumour-specific L1 mutation in the first intron of the epidermal growth factor receptor gene (EGFR) (Fig. 2a), a major oncogene amplified or otherwise altered in >60 % of GBM cases [6].